1. Home
  2. JXG vs MYO Comparison

JXG vs MYO Comparison

Compare JXG & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JX Luxventure Limited

JXG

JX Luxventure Limited

N/A

Current Price

$9.00

Market Cap

84.3M

Sector

N/A

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$1.62

Market Cap

68.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JXG
MYO
Founded
N/A
2004
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.3M
68.9M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
JXG
MYO
Price
$9.00
$1.62
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
13.4K
766.2K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
$0.77
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.23
$0.61
52 Week High
$12.00
$1.89

Technical Indicators

Market Signals
Indicator
JXG
MYO
Relative Strength Index (RSI) 55.68 58.31
Support Level $7.37 $0.69
Resistance Level $10.09 $1.89
Average True Range (ATR) 0.56 0.19
MACD 0.20 -0.01
Stochastic Oscillator 100.00 56.03

Price Performance

Historical Comparison
JXG
MYO

About JXG JX Luxventure Limited

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products. The Company's operations are located in the PRC and all of the Company's revenue is derived from sales to customers in the PRC region.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: